RxDoctor Payments Data

Vinod Mungalpara, MD

Pain Medicine · Bakersfield, CANPI 1942278668

Payments from drug & device makers

$691in general payments, 2019–2025

Across 29 payments — averaging $23.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Scilex Pharmaceuticals Inc.$228
  • Si-bone, Inc.$125
  • Painteq LLC$90
  • Daiichi Sankyo Inc.$63
  • Medtronic$63
  • Forte Bio-pharma LLC$45
  • plus $77 from 3 others

What the payments were for

  • Food & beverage$691100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$691 in reported general payments places this provider in the 30th percentile of 840 pain medicine providers in California.

See all pain medicine providers in California

Medicare billing

Part B allowed, 2024
$447,513
Medicare patients
914
Services billed
4,176

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen2,120$48,721
ZtlidoLidocaine75$41,447
Lidocaine166$17,105
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen334$8,121
Diclofenac Sodium175$7,482
Buprenorphine38$6,594
Gabapentin473$3,702
Naloxone Hcl40$2,668
Morphine Sulfate ErMorphine Sulfate167$2,492
Acetaminophen-CodeineAcetaminophen With Codeine110$1,957
Pregabalin142$1,893
Tizanidine Hcl363$1,661
Cyclobenzaprine Hcl261$1,534
Ibuprofen165$1,006
Tramadol Hcl185$892

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Scilex Pharmaceuticals Inc.Ztlido$228$41,44775 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 30th percentile of 840 pain medicine providers in California.

Other pain medicine in Bakersfield

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →